D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
42,800
-1,800 (-4.04%)
Sep 22, 2026, 3:30 PM KST

D&D Pharmatech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-21,605-23,555-28,6233,934-136,067-68,224
Depreciation & Amortization
5,6625,5315,5274,42813,73911,901
Loss (Gain) From Sale of Assets
22.30.13118.3884.78-21,524-
Asset Writedown & Restructuring Costs
--9,199-4,582119,722-
Loss (Gain) on Equity Investments
5,3634,815-1,8391,7879,148-
Stock-Based Compensation
3,2301,472762.942,8434,0575,576
Other Operating Activities
-15,798-11,327-1,510-15,025-39,488-7,399
Change in Accounts Receivable
-2,6023,985-3,921-3,618-231.5897.49
Change in Other Net Operating Assets
833.34-2,061-1,5191,030-2,4395,304
Operating Cash Flow
-24,894-21,139-21,805-9,117-53,083-51,945
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-41.3-64.41-395.75-45.22-711.88-1,615
Sale of Property, Plant & Equipment
--8.87323.21240.02-
Sale (Purchase) of Intangibles
---20--7.03-603.83
Investment in Securities
-230,480-----
Other Investing Activities
-149.58-25.84-132.64-9.84-263.02
Investing Cash Flow
-230,671-90.25-539.53268.14-478.89-1,955

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---1,0003,2176,329
Total Debt Issued
226,487--1,0003,2176,329
Short-Term Debt Repaid
--925.12----
Long-Term Debt Repaid
--1,843-1,730-1,625-1,378-774.99
Total Debt Repaid
-1,951-2,769-1,730-1,625-1,378-774.99
Net Debt Issued (Repaid)
224,536-2,769-1,730-625.251,8395,554
Issuance of Common Stock
7,3507,38237,980-1473,014
Other Financing Activities
-4,16419,581-0-4.67-0-0
Financing Cash Flow
227,72324,19536,251-629.921,98667,692

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
103.79-95.36465.06-382.51,1231,554
Net Cash Flow
-27,7382,87014,372-9,862-50,45415,346

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-24,936-21,203-22,201-9,163-53,795-53,560
Free Cash Flow Growth
------
Free Cash Flow Margin
-906.61%-493.38%-194.12%-49.06%-8810.69%-3926.36%
Free Cash Flow Per Share
-571.19-482.64-547.42-244.19-1668.57-1627.16
Levered Free Cash Flow
-40,226-27,099-13,079-28,427-29,052-14,039
Unlevered Free Cash Flow
-38,291-26,805-12,695-27,535-27,203-13,407

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
354.16396.9400.26454.26510.72247.05
Cash Income Tax Paid
6.42-22.7455.41,89683.39354.64
Change in Working Capital
-1,7691,925-5,440-2,587-2,6706,201